Ralph A. Tripp | Academic Influence

Ralph A. Tripp's AcademicInfluence.com Rankings

Ralph A. Tripp

Biology

#10702

World Rank

#14054

Historical Rank

Virology

#253

World Rank

#260

Historical Rank

Microbiology

#602

World Rank

#670

Historical Rank

biology Degrees

Download Badge

Biology

Ralph A. Tripp's Degrees

PhD Microbiology University of Georgia
Masters Microbiology University of Georgia
Bachelors Biology University of Georgia

Similar Degrees You Can Earn

Best Online Bachelor's in Biology

Why Is Ralph A. Tripp Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Ralph A. Tripp's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus (2000) (1779)
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted State6 gene (1996) (1459)
Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells (1996) (1242)
Defective Lymphoid Development in Mice Lacking Jak3 (1995) (687)
Rapid and sensitive detection of respiratory virus molecular signatures using a silver nanorod array SERS substrate. (2006) (576)
CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. (1997) (555)
Involvement of Toll-Like Receptor 4 in Innate Immunity to Respiratory Syncytial Virus (2001) (525)
Effector CD4+ and CD8+ T‐cell mechanisms in the control of respiratory virus infections (1997) (482)
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein (2001) (420)
Novel nanostructures for SERS biosensing (2008) (383)
Stress alters immune function and disease resistance in chinook salmon (Oncorhynchus tshawytscha). (1989) (367)
Respiratory Syncytial Virus Activates Innate Immunity through Toll-Like Receptor 2 (2008) (260)
Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells (1998) (243)
Rapid microRNA (miRNA) detection and classification via surface-enhanced Raman spectroscopy (SERS). (2008) (214)
Pathogenesis of an Infectious Mononucleosis-like Disease Induced by a Murine γ-Herpesvirus: Role for a Viral Superantigen? (1997) (184)
Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease (2020) (183)
Quantitative analysis of the influenza virus-specific CD4+ T cell memory in the absence of B cells and Ig. (1996) (182)
Establishment and Persistence of Virus‐Specific CD4+ and CD8+ T Cell Memory (1996) (180)
Visible-Light-Activated Bactericidal Functions of Carbon "Quantum" Dots. (2016) (174)
Human Metapneumovirus: Lessons Learned over the First Decade (2011) (164)
Respiratory Syncytial Virus G and/or SH Protein Alters Th1 Cytokines, Natural Killer Cells, and Neutrophils Responding to Pulmonary Infection in BALB/c Mice (1999) (161)
Recruitment and proliferation of CD8+ T cells in respiratory virus infections. (1995) (156)
Temporal loss of the activated L-selectin-low phenotype for virus-specific CD8+ memory T cells. (1995) (150)
Respiratory Syncytial Virus G Protein and G Protein CX3C Motif Adversely Affect CX3CR1+ T Cell Responses (2006) (148)
Cortisol mediated suppression of salmonid lymphocyte responses in vitro. (1987) (146)
Characteristics of the influenza virus-specific CD8+ T cell response in mice homozygous for disruption of the H-2lAb gene. (1995) (139)
RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy (2009) (138)
One-step assay for detecting influenza virus using dynamic light scattering and gold nanoparticles. (2011) (137)
Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes. (1996) (132)
Identification and classification of respiratory syncytial virus (RSV) strains by surface-enhanced Raman spectroscopy and multivariate statistical techniques (2008) (130)
Counting single native biomolecules and intact viruses with color-coded nanoparticles. (2006) (129)
Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice. (2009) (119)
Roles of Host Gene and Non-coding RNA Expression in Virus Infection (2018) (114)
Enhanced Disease and Pulmonary Eosinophilia Associated with Formalin-Inactivated Respiratory Syncytial Virus Vaccination Are Linked to G Glycoprotein CX3C-CX3CR1 Interaction and Expression of Substance P (2003) (112)
Bone marrow can function as a lymphoid organ during a primary immune response under conditions of disrupted lymphocyte trafficking. (1997) (107)
CD8+ T-cell memory to viruses. (1994) (105)
Human Metapneumovirus Persists in BALB/c Mice despite the Presence of Neutralizing Antibodies (2004) (103)
Immune CD4+ T cells promote the clearance of influenza virus from major histocompatibility complex class II -/- respiratory epithelium (1996) (102)
Flexible and mechanical strain resistant large area SERS active substrates. (2012) (102)
Respiratory Syncytial Virus G and/or SH Glycoproteins Modify CC and CXC Chemokine mRNA Expression in the BALB/c Mouse (2000) (101)
Generation of H7N9-specific human polyclonal antibodies from a transchromosomic goat (caprine) system (2019) (99)
Vaccination To Induce Antibodies Blocking the CX3C-CX3CR1 Interaction of Respiratory Syncytial Virus G Protein Reduces Pulmonary Inflammation and Virus Replication in Mice (2009) (99)
The host response and molecular pathogenesis associated with respiratory syncytial virus infection. (2009) (96)
Rapid and Sensitive Detection of Rotavirus Molecular Signatures Using Surface Enhanced Raman Spectroscopy (2010) (93)
Verdinexor, a Novel Selective Inhibitor of Nuclear Export, Reduces Influenza A Virus Replication In Vitro and In Vivo (2014) (93)
Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA. (2002) (92)
Respiratory syncytial virus (RSV) attachment and nonstructural proteins modify the type I interferon response associated with suppressor of cytokine signaling (SOCS) proteins and IFN-stimulated gene-15 (ISG15) (2008) (90)
The G Glycoprotein of Respiratory Syncytial Virus Depresses Respiratory Rates through the CX3C Motif and Substance P (2003) (90)
Label-free SERS detection of microRNA based on affinity for an unmodified silver nanorod array substrate. (2010) (89)
Rabies Virus Expressing Dendritic Cell-Activating Molecules Enhances the Innate and Adaptive Immune Response to Vaccination (2010) (89)
Detection and differentiation of foodborne pathogenic bacteria in mung bean sprouts using field deployable label-free SERS devices. (2013) (89)
Cytokine production in the immune response to murine gammaherpesvirus 68 (1996) (88)
Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients (2009) (87)
Cytokines and respiratory syncytial virus infection. (2005) (87)
Real-Time Detection of Virus Particles and Viral Protein Expression with Two-Color Nanoparticle Probes (2005) (85)
Label-free detection of micro-RNA hybridization using surface-enhanced Raman spectroscopy and least-squares analysis. (2012) (85)
Respiratory syncytial virus modifies microRNAs regulating host genes that affect virus replication (2012) (85)
Respiratory Syncytial Virus Infection and G and/or SH Protein Expression Contribute to Substance P, Which Mediates Inflammation and Enhanced Pulmonary Disease in BALB/c Mice (2000) (83)
The role of human adenovirus early region 3 proteins (gp19K, 10.4K, 14.5K, and 14.7K) in a murine pneumonia model (1996) (83)
An Au/Si hetero-nanorod-based biosensor for Salmonella detection (2008) (83)
The Immune Response to Human Metapneumovirus Is Associated with Aberrant Immunity and Impaired Virus Clearance in BALB/c Mice (2005) (80)
Respiratory syncytial virus proteins modulate suppressors of cytokine signaling 1 and 3 and the type I interferon response to infection by a toll-like receptor pathway. (2009) (79)
Fabrication and characterization of a multiwell array SERS chip with biological applications. (2009) (73)
Comparison of the receptor binding properties of contemporary swine isolates and early human pandemic H1N1 isolates (Novel 2009 H1N1). (2011) (73)
Tuning into immunological dissonance: an experimental model for infectious mononucleosis. (1997) (71)
Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naïve and Formalin-Inactivated RSV-Immunized BALB/c Mice (2010) (69)
Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab')2 components mediates reduced pulmonary inflammation in mice. (2009) (68)
CD40 Ligand (CD154) Enhances the Th1 and Antibody Responses to Respiratory Syncytial Virus in the BALB/c Mouse (2000) (67)
Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes (1993) (67)
Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity (2019) (66)
Bioconjugated nanoparticle detection of respiratory syncytial virus infection (2007) (65)
Detection of Mycoplasma pneumoniae in Simulated and True Clinical Throat Swab Specimens by Nanorod Array-Surface-Enhanced Raman Spectroscopy (2010) (65)
Differentiation and classification of bacteria using vancomycin functionalized silver nanorods array based surface-enhanced Raman spectroscopy and chemometric analysis. (2015) (64)
Antibodies to the central conserved region of respiratory syncytial virus (RSV) G protein block RSV G protein CX3C-CX3CR1 binding and cross-neutralize RSV A and B strains. (2012) (63)
An in vitro model of the leukocyte interactions associated with granuloma formation in Mycobacterium tuberculosis infection (2007) (60)
Interferon Lambda Upregulates IDO1 Expression in Respiratory Epithelial Cells After Influenza Virus Infection. (2015) (60)
Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins (2005) (60)
Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challenge. (2007) (59)
Infectious Agent Detection With SERS-Active Silver Nanorod Arrays Prepared by Oblique Angle Deposition (2008) (58)
Quantitative Surface-Enhanced Raman Spectroscopy Based Analysis of MicroRNA Mixtures (2009) (57)
Host gene targets for novel influenza therapies elucidated by high‐throughput RNA interference screens (2012) (54)
Pathogenesis of respiratory syncytial virus infection. (2004) (53)
Respiratory syncytial virus F and G proteins induce interleukin 1alpha, CC, and CXC chemokine responses by normal human bronchoepithelial cells. (2010) (53)
Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem (2017) (53)
An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice. (2015) (53)
Prior airway exposure to allergen increases virus-induced airway hyperresponsiveness. (2003) (53)
Respiratory syncytial virus: prospects for new and emerging therapeutics (2017) (52)
Respiratory Syncytial Virus (RSV) Infects Neuronal Cells and Processes That Innervate the Lung by a Process Involving RSV G Protein (2006) (52)
Induction and Role of Indoleamine 2,3 Dioxygenase in Mouse Models of Influenza A Virus Infection (2013) (51)
The failure of interleukin-10-deficient mice to develop airway hyperresponsiveness is overcome by respiratory syncytial virus infection in allergen-sensitized/challenged mice. (2002) (51)
A Respiratory Syncytial Virus (RSV) Anti-G Protein F(ab′)2 Monoclonal Antibody Suppresses Mucous Production and Breathing Effort in RSV rA2-line19F-Infected BALB/c Mice (2013) (50)
Novel H7N9 Influenza Virus Shows Low Infectious Dose, High Growth Rate, and Efficient Contact Transmission in the Guinea Pig Model (2013) (49)
Avian Influenza Viruses Infect Primary Human Bronchial Epithelial Cells Unconstrained by Sialic Acid α2,3 Residues (2011) (49)
Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs (2013) (48)
Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection. (2013) (48)
Cellular mechanisms of glucocorticoid immunosuppression in salmon (1987) (48)
Virus-Vectored Influenza Virus Vaccines (2014) (47)
Replication and pathogenesis associated with H5N1, H5N2, and H5N3 low-pathogenic avian influenza virus infection in chickens and ducks (2009) (47)
Substance P receptor expression on lymphocytes is associated with the immune response to respiratory syncytial virus infection (2002) (46)
MicroRNA Regulation of Human Protease Genes Essential for Influenza Virus Replication (2012) (46)
Nanoparticle Vaccines Encompassing the Respiratory Syncytial Virus (RSV) G Protein CX3C Chemokine Motif Induce Robust Immunity Protecting from Challenge and Disease (2013) (45)
Prophylaxis with a Respiratory Syncytial Virus (RSV) Anti-G Protein Monoclonal Antibody Shifts the Adaptive Immune Response to RSV rA2-line19F Infection from Th2 to Th1 in BALB/c Mice (2014) (44)
Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis. (2004) (44)
Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium (2015) (44)
Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective (2017) (44)
Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesis (2016) (43)
Pause on avian flu transmission research. (2012) (41)
Visible Light‐Induced Photoeletrochemical and Antimicrobial Properties of Hierarchical CuBi2O4 by Facile Hydrothermal Synthesis (2016) (39)
Targeting Organic Anion Transporter 3 with Probenecid as a Novel Anti-Influenza A Virus Strategy (2012) (39)
Detection and Differentiation of Avian Mycoplasmas by Surface-Enhanced Raman Spectroscopy Based on a Silver Nanorod Array (2011) (38)
ADAMTS5 Is a Critical Regulator of Virus-Specific T Cell Immunity (2016) (38)
Transmission Studies Resume for Avian Flu (2013) (37)
Highly Sensitive and Transparent Surface Enhanced Raman Scattering Substrates Made by Active Coldly Condensed Ag Nanorod Arrays (2012) (37)
Neutralizing Anti-F Glycoprotein and Anti-Substance P Antibody Treatment Effectively Reduces Infection and Inflammation Associated with Respiratory Syncytial Virus Infection (2002) (37)
Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice (2012) (36)
Perspective on the host response to human metapneumovirus infection: what can we learn from respiratory syncytial virus infections? (2005) (36)
A respiratory syncytial virus (RSV) vaccine based on parainfluenza virus 5 (PIV5). (2014) (35)
Anti‐respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model (2018) (35)
Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication. (2015) (35)
Therapeutic targeting of respiratory syncytial virus G-protein. (2010) (35)
Animal models for evaluation of influenza vaccines. (2009) (34)
Development of a Zika vaccine (2016) (34)
Gain-of-Function Experiments on H7N9 (2013) (33)
Pause on Avian Flu Transmission Research (2012) (32)
Primary in vitro stimulation of antibody production by rainbow trout lymphocytes. (1986) (32)
Novel ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV2 (2020) (32)
The cytotoxic T-lymphocyte response to Sendai virus is unimpaired in the absence of gamma interferon (1997) (32)
Susceptibility of influenza viruses to hypothiocyanite and hypoiodite produced by lactoperoxidase in a cell-free system (2018) (31)
TH1- AND TH2-TYPE CYTOKINE EXPRESSION BY ACTIVATED T LYMPHOCYTES FROM THE LUNG AND SPLEEN DURING THE INFLAMMATORY RESPONSE TO RESPIRATORY SYNCYTIAL VIRUS (2000) (31)
Human Metapneumovirus Establishes Persistent Infection in the Lungs of Mice and Is Reactivated by Glucocorticoid Treatment (2009) (31)
The Thr205 Phosphorylation Site within Respiratory Syncytial Virus Matrix (M) Protein Modulates M Oligomerization and Virus Production (2014) (31)
Reconstitution of early lymphoid proliferation and immune function in Jak3-deficient mice by interleukin-3. (1999) (31)
Laser light suicide of proliferating virus-specific CD8+ T cells in an in vivo response. (1995) (30)
Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle (2016) (29)
Comparative Pathology in Ferrets Infected with H1N1 Influenza A Viruses Isolated from Different Hosts (2011) (29)
An innate defense peptide BPIFA1/SPLUNC1 restricts influenza A virus infection (2017) (28)
Engineering Enhanced Vaccine Cell Lines To Eradicate Vaccine-Preventable Diseases: the Polio End Game (2015) (28)
Human Norovirus: Experimental Models of Infection (2019) (28)
CD40 ligand (CD154) improves the durability of respiratory syncytial virus DNA vaccination in BALB/c mice. (2003) (28)
Antiviral Efficacy of Verdinexor In Vivo in Two Animal Models of Influenza A Virus Infection (2016) (27)
Human respiratory syncytial virus non-structural protein NS1 modifies miR-24 expression via transforming growth factor-β. (2015) (26)
Dual Proinflammatory and Antiviral Properties of Pulmonary Eosinophils in Respiratory Syncytial Virus Vaccine-Enhanced Disease (2014) (26)
Association of adenovirus 36 infection with adiposity and inflammatory-related markers in children. (2014) (26)
Serum Mannose-Binding Lectin Levels are Linked with Respiratory Syncytial Virus (RSV) Disease (2008) (26)
Memory T Cells Generated by Prior Exposure to Influenza Cross React with the Novel H7N9 Influenza Virus and Confer Protective Heterosubtypic Immunity (2015) (26)
Indoleamine 2,3-dioxygenase (IDO) activity during the primary immune response to influenza infection modifies the memory T cell response to influenza challenge. (2014) (25)
Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity. (2017) (25)
RNA Interference Inhibits Respiratory Syncytial Virus Replication and Disease Pathogenesis without Inhibiting Priming of the Memory Immune Response (2008) (25)
Aerosol inoculation with a sub-lethal influenza virus leads to exacerbated morbidity and pulmonary disease pathogenesis. (2011) (25)
Antiviral cytotoxic activity across a species barrier in mixed xenogeneic chimeras: functional restriction to host MHC. (1998) (24)
Emerging Technologies in Nanotechnology-Based Pathogen Detection (2009) (24)
Non‐canonical autophagy functions of ATG16L1 in epithelial cells limit lethal infection by influenza A virus (2021) (24)
Identification of individual genotypes of measles virus using surface enhanced Raman spectroscopy. (2010) (24)
Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus (2016) (24)
siRNA Genome Screening Approaches to Therapeutic Drug Repositioning (2013) (24)
Modification of the Sendai virus-specific antibody and CD8+ T-cell responses in mice homozygous for disruption of the interleukin-4 gene (1997) (23)
Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge (2017) (23)
Cytotoxic T-Lymphocyte Precursor Frequencies in BALB/c Mice after Acute Respiratory Syncytial Virus (RSV) Infection or Immunization with a Formalin-Inactivated RSV Vaccine (1998) (23)
Immunopathology of RSV: An Updated Review (2021) (23)
Human Respiratory Syncytial Virus (2020) (23)
TH(1)- and TH(2)-TYPE cytokine expression by activated t lymphocytes from the lung and spleen during the inflammatory response to respiratory syncytial virus. (2000) (22)
Selinexor, a novel selective inhibitor of nuclear export, reduces SARS-CoV-2 infection and protects the respiratory system in vivo (2021) (22)
Hypothiocyanite produced by human and rat respiratory epithelial cells inactivates extracellular H1N2 influenza A virus (2015) (22)
Verdinexor (KPT-335), a Selective Inhibitor of Nuclear Export, Reduces Respiratory Syncytial Virus Replication In Vitro (2018) (22)
The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to Infection (2017) (22)
Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses (2018) (21)
MicroRNA Regulation of Human Genes Essential for Influenza A (H7N9) Replication (2016) (21)
Bat cells from Pteropus alecto are susceptible to influenza A virus infection and reassortment (2013) (21)
Serological cross-reactivity of members of the Metapneumovirus genus. (2004) (20)
MicroRNA-555 has potent antiviral properties against poliovirus. (2016) (20)
Recombinant vaccines for influenza virus. (2008) (20)
Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice (2013) (20)
Development of improved vaccine cell lines against rotavirus (2017) (19)
Tumor Progression Locus 2 Promotes Induction of IFNλ, Interferon Stimulated Genes and Antigen-Specific CD8+ T Cell Responses and Protects against Influenza Virus (2015) (19)
Identification of Virulence Determinants in Influenza Viruses (2014) (19)
Nebulized live-attenuated influenza vaccine provides protection in ferrets at a reduced dose. (2012) (19)
The brume surrounding respiratory syncytial virus persistence. (2004) (19)
Targeting Cell Division Cycle 25 Homolog B To Regulate Influenza Virus Replication (2013) (18)
Adenovirus 36, adiposity, and bone strength in late‐adolescent females (2013) (18)
Aerosol vaccination induces robust protective immunity to homologous and heterologous influenza infection in mice. (2011) (18)
Molecular and cellular mechanisms in the viral exacerbation of asthma (2008) (18)
Layer-By-Layer Nanoparticle Vaccines Carrying the G Protein CX3C Motif Protect against RSV Infection and Disease (2015) (17)
Silver nanotriangle array based LSPR sensor for rapid coronavirus detection (2022) (17)
Enhanced immunogenicity following miR-155 incorporation into the influenza A virus genome. (2017) (16)
CD4+ T Cell Frequencies and Th1/Th2 Cytokine Patterns Expressed in the Acute and Memory Response to Respiratory Syncytial Virus I-Ed-Restricted Peptides (2001) (16)
Respiratory Syncytial Virus G and / or SH Protein Alters Th 1 Cytokines , Natural Killer Cells , and Neutrophils Responding to Pulmonary Infection in BALB / c Mice (1999) (16)
Antiviral Responses by Swine Primary Bronchoepithelial Cells Are Limited Compared to Human Bronchoepithelial Cells Following Influenza Virus Infection (2013) (16)
A universal mammalian vaccine cell line substrate (2017) (16)
Advances in and the potential of vaccines for respiratory syncytial virus (2013) (15)
Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro (2021) (15)
Pulmonary delivery of respiratory syncytial virus DNA vaccines using macroaggregated albumin particles. (2004) (15)
Multiplexed screening of natural humoral immunity identifies antibodies at fine specificity for complex and dynamic viral targets (2014) (15)
MicroRNA screening identifies miR-134 as a regulator of poliovirus and enterovirus 71 infection (2017) (14)
Innate and adaptive immune responses in respiratory virus infection: implications for the clinic (2020) (14)
Molecular epidemiology of swine influenza A viruses in the Southeastern United States, highlights regional differences in circulating strains. (2017) (14)
Dual oxidase 1 promotes antiviral innate immunity (2021) (14)
Emerging small and large molecule therapeutics for respiratory syncytial virus (2020) (14)
A Potent Neutralizing Site III-Specific Human Antibody Neutralizes Human Metapneumovirus In Vivo (2019) (14)
Passage of low-pathogenic avian influenza (LPAI) viruses mediates rapid genetic adaptation of a wild-bird isolate in poultry (2010) (13)
Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine Types (2019) (13)
Enhancing viral vaccine production using engineered knockout vero cell lines – A second look (2018) (13)
Drug analog inhibition of indoleamine 2,3‐dioxygenase (IDO) activity modifies pattern recognition receptor expression and proinflammatory cytokine responses early during influenza virus infection (2014) (13)
Original Antigenic Sin and Respiratory Syncytial Virus Vaccines (2019) (12)
Targeting the pro-inflammatory factor CCL2 (MCP-1) with Bindarit for influenza A (H7N9) treatment (2017) (12)
Gene-edited vero cells as rotavirus vaccine substrates (2019) (12)
Therapeutic applications of RNAi for silencing virus replication. (2009) (12)
Vero Cells as a Mammalian Cell Substrate for Human Norovirus (2020) (12)
Respiratory Syncytial Virus (RSV) G Protein Vaccines With Central Conserved Domain Mutations Induce CX3C-CX3CR1 Blocking Antibodies (2021) (12)
A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge. (2017) (12)
Losartan Inhibits SARS-CoV-2 Replication in Vitro. (2021) (11)
Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B Viruses (2018) (11)
Up-to-date role of biologics in the management of respiratory syncytial virus (2020) (10)
The use of a handheld Raman system for virus detection (2012) (10)
CD4(+) T cell frequencies and Th1/Th2 cytokine patterns expressed in the acute and memory response to respiratory syncytial virus I-E(d)-restricted peptides. (2001) (10)
Evasion of host immune responses by tumours and viruses. (1994) (10)
Antiviral effects of inhibiting host gene expression. (2015) (10)
Respiratory Syncytial Virus G Protein and G Protein CX 3 C Motif Adversely Affect CX 3 CR 1 T Cell Responses (2006) (10)
A Novel Influenza Virus Hemagglutinin-Respiratory Syncytial Virus (RSV) Fusion Protein Subunit Vaccine against Influenza and RSV (2013) (9)
Host gene expression and respiratory syncytial virus infection. (2013) (9)
Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV) (2021) (9)
Isothermal amplification and fluorescent detection of SARS-CoV-2 and SARS-CoV-2 variant virus in nasopharyngeal swabs (2021) (9)
Swine Influenza Virus PA and Neuraminidase Gene Reassortment into Human H1N1 Influenza Virus Is Associated with an Altered Pathogenic Phenotype Linked to Increased MIP-2 Expression (2015) (8)
Gammaherpesvirus infection modulates the temporal and spatial expression of SCGB1A1 (CCSP) and BPIFA1 (SPLUNC1) in the respiratory tract (2014) (8)
ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2 (2021) (8)
Respiratory Syncytial Virus (RSV) Modulation at the Virus-Host Interface Affects Immune Outcome and Disease Pathogenesis (2013) (8)
Polymerase Discordance in Novel Swine Influenza H3N2v Constellations Is Tolerated in Swine but Not Human Respiratory Epithelial Cells (2014) (8)
Gain-of-function experiments on H7N9. (2013) (7)
Current influenza vaccines for poultry and other animal species. (2008) (7)
Exosome-mediated human norovirus infection (2020) (7)
Structure, Immunogenicity, and Conformation-Dependent Receptor Binding of the Postfusion Human Metapneumovirus F Protein (2021) (7)
Human Respiratory Syncytial Virus: An Introduction. (2016) (6)
Surveillance of feral cats for influenza A virus in North Central Florida (2011) (6)
Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication (2022) (6)
Quantification of RSV Infectious Particles by Plaque Assay and Immunostaining Assay. (2016) (6)
Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins (2021) (5)
Novel H 7 N 9 Influenza Virus Shows Low Infectious Dose , High Growth Rate , and Efficient Contact Transmission in the Guinea Pig Model (2013) (5)
Glucocorticoid regulation of salmonid B lymphocytes (1988) (5)
Frontiers in RNAi (2014) (5)
Erratum: An innate defense peptide BPIFA1/SPLUNC1 restricts influenza A virus infection (2018) (5)
Detection of neuraminidase stalk motifs associated with enhanced N1 subtype influenza A virulence via Raman spectroscopy. (2015) (5)
Role of cytokines in the development and maintenance of memory T cells during respiratory viral infection. (2003) (5)
MicroRNA and Nonsense Transcripts as Putative Viral Evasion Mechanisms (2019) (5)
ADAMTS 5 Is a Critical Regulator of Virus-Specific T Cell Immunity (2017) (5)
Regulation of Mumps Virus Replication and Transcription by Kinase RPS6KB1 (2020) (4)
Modeling respiratory syncytial virus cytopathogenesis in the human airway. (2013) (4)
MicroRNA Profiling from RSV-Infected Biofluids, Whole Blood, and Tissue Samples. (2016) (4)
Rapid and quantitative detection of respiratory viruses using surface-enhanced Raman spectroscopy and machine learning. (2022) (4)
RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein (2022) (4)
Silver nanorod arrays as highly sensitive SERS substrates for viral detection (2006) (4)
Reversible disruption of XPO1-mediated nuclear export inhibits respiratory syncytial virus (RSV) replication (2021) (4)
Engineering enhanced vaccine cell lines to eradicate vaccine preventable diseases: the polio endgame (VAC9P.1107) (2015) (4)
Current Progress on Surface-Enhanced Raman Scattering Chemical/Biological Sensing (2012) (4)
Pneumovirus and Metapneumovirus: Respiratory Syncytial Virus and Human Metapneumovirus (2010) (4)
G-Protein-Coupled Receptor and Ion Channel Genes Used by Influenza Virus for Replication (2021) (4)
The WD and linker domains of ATG16L1 required for non-canonical autophagy limit lethal respiratory infection by influenza A virus at epithelial surfaces (2020) (4)
Detection of Swine Influenza Virus in Nasal Specimens by Reverse Transcription-Loop-Mediated Isothermal Amplification (RT-LAMP). (2020) (4)
ADAMTS5 and its substrate versican play a critical role in influenza virus immunity (2017) (3)
Molecular epidemiology and glycomics of swine influenza viruses circulating in commercial swine farms in the southeastern and midwest United States. (2020) (3)
Erratum to: Serial passage in ducks of a low-pathogenic avian influenza virus isolated from a chicken reveals a high mutation rate in the hemagglutinin that is likely due to selection in the host (2015) (3)
A Respiratory Syncytial Virus ( RSV ) Anti-G Protein F ( ab ′ ) 2 Monoclonal Antibody Suppresses Mucous Production and Breathing Effort in RSV rA 2-line 19 F-Infected BALB / c Mice (3)
Serial passage in ducks of a low-pathogenic avian influenza virus isolated from a chicken reveals a high mutation rate in the hemagglutinin that is likely due to selection in the host (2015) (3)
Virally Encoded MicroRNA (miRNA) Candidates for Gene Silencing (2008) (3)
Drug repositioning of Clopidogrel or Triamterene to inhibit influenza virus replication in vitro (2021) (3)
Zinc affects miR-548n, SMAD4, SMAD5 expression in HepG2 hepatocyte and HEp-2 lung cell lines (2015) (3)
An innate defence role for BPIFA1/SPLUNC1 against influenza-A virus infection (2015) (3)
MicroRNA-134 regulates poliovirus replication by IRES targeting (2017) (3)
Addressing the Re-emergence of Poliovirus (2014) (3)
Isothermal amplification using sequence-specific fluorescence detection of SARS coronavirus 2 and variants in nasal swabs (2022) (3)
Application of RNA Interference to Viral Diseases (2010) (2)
Intellectual property rights for agriculture in international trade and investment agreements: A plant breeding perspective (2006) (2)
Advances in Vaccine Development (2021) (2)
Virologic Differences Do Not Fully Explain the Diversification of Swine Influenza Viruses in the United States (2016) (2)
CorrigendumCorrigendum to “Serological cross-reactivity of members of the Metapneumovirus genus” [Virus Res. 105 (2004) 67–73] (2005) (2)
Correction: ADAMTS5 Is a Critical Regulator of Virus-Specific T Cell Immunity (2019) (2)
Influenza Virus (Orthomyxovirus), Infection and Immunity (1998) (2)
Methods in Molecular Biology, vol. 21, Natural Killer Cell Protocols, Cellular and Molecular Methods, Edited by Kerry S. Campbell and Marco Colonna. Humana Press 2000. ISBN: 0-89603-683-9, $99.50. (2000) (2)
Novel Nanoarray SERS Substrates Used for High Sensitivity Virus Biosensing and Classification (2009) (2)
Rapid Identification of Bacterial Pathogens of Military Interest Using Surface-Enhanced Raman Spectroscopy (2014) (2)
A pioneering countermeasure against measles virus. (2015) (2)
Structural basis for ultrapotent antibody-mediated neutralization of human metapneumovirus (2022) (2)
From COVID-19 to the Common Cold: Novel Host-Targeted, Pan-Respiratory Antiviral Small Molecule Therapeutics (2021) (2)
Hypothiocyanite produced by human and rat respiratory epithelial cells inactivates extracellular H1N2 influenza A virus (2015) (2)
Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon response (2023) (2)
SERS-based viral fingerprinting: current capabilities and challenges (2010) (2)
Influenza B Virus (IBV) Immune-Mediated Disease in C57BL/6 Mice (2022) (2)
The Hypothiocyanite and Amantadine Combination Treatment Prevents Lethal Influenza A Virus Infection in Mice (2022) (2)
Rapid Detection of SARS-CoV-2 RNA in Human Nasopharyngeal Specimens Using Surface-Enhanced Raman Spectroscopy and Deep Learning Algorithms (2022) (2)
Subsisting H1N1 influenza memory responses are insufficient to protect from pandemic H1N1 influenza challenge in C57BL/6 mice. (2013) (2)
Immunobiology of influenza infection: approaches for an emerging zoonotic disease: 2008. (2008) (1)
9.2 Regulation of the salmonid immune response by cortisol (1989) (1)
Roles of Non-coding RNAs in Respiratory Syncytial Virus (RSV) Infection. (2017) (1)
Invitro immunosuppressive effects of cortisol on salmonid lymphocytes (1987) (1)
Pathogenesis of an Infectious Mononucleosis-like Disease Induced by a Murine (cid:103) -Herpesvirus: Role for a Viral Superantigen? (1997) (1)
Influence of aging on T cell repertoire and cellular immunity to viral infections-challenges for effective influenza virus vaccines for the elderly. (2008) (1)
Virus in the BALB/c Mouse Antibody Responses to Respiratory Syncytial CD40 Ligand (CD154) Enhances the Th1 and (2013) (1)
A role for neuraminidase antibodies in protection from pandemic influenza (2008) (1)
Intellectual property rights in the breeding industry : farmers' interests (2006) (1)
Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication (2022) (1)
Synthetic LbL nanoparticle vaccines containing the chemokine mimic epitope of RSV-G protein and a CD8 epitope of RSV-M2 protein elicit broad-based cellular and humoral responses (155.7) (2011) (1)
Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like Coronaviruses (2022) (1)
Spherical and Anisotropic Silver Nanomaterials in Medical Diagnosis (2010) (1)
Antiviral agents for influenza virus (2015) (1)
Exploiting MicroRNA (miRNA) Profiles for Diagnostics (2016) (1)
Inhibition of Indoleamine 2,3-dioxygenase (IDO) enhances the memory CD8 T cell response and modulates the immunodominance hierarchy following influenza infection (48.17) (2012) (1)
Inhaled Countermeasures for Respiratory Tract Viruses (2016) (1)
OFFICIAL JOURNAL OF THE SOCIETY FOR MUCOSAL IMMUNOLOGY, PUBLISHED BY SPRINGER NATURE (2017) (1)
Optimization of a multi-well array SERS chip (2009) (1)
Therapeutic Considerations for Middle East Respiratory Syndrome Coronavirus (2013) (1)
Nanoparticle vaccines comprising the respiratory syncytial virus G Protein CX3C chemokine motif induce robust immunity protecting from challenge and disease (P4513) (2013) (0)
How the structure of viral peptide-MHC complexes influences cytotoxic T cell immunity to viral infections. (2008) (0)
Erratum to: Serial passage in ducks of a low-pathogenic avian influenza virus isolated from a chicken reveals a high mutation rate in the hemagglutinin that is likely due to selection in the host (2016) (0)
ADAMTS7 extracellular matrix enzyme expression is required for optimal influenza-specific CD8+T cell immunity. (2018) (0)
Overview of the immune response to influenza virus infection. (2008) (0)
A Pan-respiratory Antiviral Chemotype Targeting a Transient Host Multiprotein Complex (2022) (0)
Genetic engineering of vaccine manufacturing cell lines enhances poliovirus and enterovirus 71 production (2016) (0)
LSC Abstract – The expression and function of BPIFA1 in the pulmonary innate immune response to influenza A virus infection (2015) (0)
Targeting Cell Division Cycle 25 Homolog B ( CDC 25 B ) to Regulate Influenza Virus 1 Replication (2013) (0)
Frontiers in viral immunology: sympathetic nervous system control of anti-influenza immunity. (2008) (0)
Reducing Influenza Virus Infection through shRNA- Targeting TMPRSS2 Protease (2013) (0)
Intelligent Surface-Enhanced Raman Scattering Sensor System for Virus Identification (2022) (0)
Passive narcosis for anesthesia induction in cotton rats (Sigmodon hispidus) (2016) (0)
Vaccination with recombinant PIV5 expressing influenza neuraminidase provides protection against homologous and heterologous influenza virus infection (P4291) (2013) (0)
Novel vaccination and therapeutic strategies against respiratory syncytial virus (2013) (0)
Targeting the pro-in fl ammatory factor CCL 2 ( MCP-1 ) with Bindarit for in fl uenza A ( H 7 N 9 ) treatment (2017) (0)
Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge (2022) (0)
Engineering enhanced vaccine cell lines for vaccine preventable viral diseases (2014) (0)
Can an influenza A-based delivery system overcome current challenges associated with miRNA technology? (2014) (0)
Cortical Bone Development is Lower in Ad36 Seropositive Versus Seronegative Adolescents: A 5‐Year Prospective Study (2017) (0)
Infectious Diseases, Vibrational Spectroscopic Approaches to Rapid Diagnostics (2013) (0)
Use of recombinant influenza vaccines expressing exogenous miRNAs for increased vaccine production (2019) (0)
Infected Patients Syncytial Virus Derived from B Cells of Treatment and Prophylaxis of Respiratory Potent High-Affinity Antibodies for (2009) (0)
Structure, immunogenicity, and conformation-dependent receptor binding of the post-fusion human metapneumovirus F protein (2021) (0)
Novel influenza vaccines and transcutaneous vaccine delivery systems. (2008) (0)
LSC Abstract - A systems biology approach to aid identification of the mechanisms employed by BPIFA1/SPLUNC1 to restrict influenza A virus infection in the lung (2016) (0)
Production of potent fully human polyclonal antibodies against Zaire Ebola virus in transchromosomal cattle (2015) (0)
Overview - the biology of influenza virus. (2008) (0)
2 Influenza A Virus and RNAi 2 . 1 Influenza Virus Lifecycle (2014) (0)
Serial passage in ducks of a low-pathogenic avian influenza virus isolated from a chicken reveals a high mutation rate in the hemagglutinin that is likely due to selection in the host (2015) (0)
Rapid and high-sensitive LSPR sensor for coronavirus detection (2022) (0)
Revised model for early memory T-cell protection against respiratory virus challenge (2008) (0)
Universal vaccination against influenza - should this be our policy? (2008) (0)
Pathobiology of Respiratory Syncytial Virus (RSV) (2020) (0)
RNAi Screening toward Therapeutic Drug Repurposing (2017) (0)
Elizabeth In Vivo and In Vitro Replication Nuclear Export , Reduces Influenza A Virus Verdinexor , a Novel Selective Inhibitor of (2014) (0)
Continuous passage of low pathogenic avian influenza viruses in ducks resulted in a higher frequency of amino acid mutations in the hemagglutinin of a chicken isolate in comparison to a wild bird isolate (2012) (0)
Perspectives on the immunobiology of influenza virus. (2008) (0)
BPIFA1: A Protein with an Important Role in the Inflammatory Response to Viral Infection in the Respiratory Tract (2016) (0)
Losartan promotes cell survival following SARS-CoV-2 infection in vitro (2020) (0)
Antiviral activity of cell free hypothiocyanite against various subtypes of Influenza virus (2017) (0)
Restoration of lymphopoiesis in Jak3 deficient scid mice with IL-3. (1997) (0)
, Guinea Pig Model Efficient Contact Transmission in the Infectious Dose , High Growth Rate , and Novel H 7 N 9 Influenza Virus Shows Low (2014) (0)
Innate Antiviral Cytokine Response to Swine Influenza Virus by Swine Respiratory Epithelial Cells (2021) (0)
Emerging Technologies in Nanotechnology-Based Pathogen (2009) (0)
Functional Restriction to Host MHC Barrier in Mixed Xenogeneic Chimeras : Antiviral Cytotoxic Activity Across a Species (1998) (0)
Virus-specific memory T cell recruitment to the lung airways during steady-state and inflammatory conditions. (2008) (0)
Human and rat epithelial cells inactivate extracellular influenza A virus via H2O2-dependent hypothiocyanite (2016) (0)
ADAMTS7: an essential enzyme for adaptive immunity (2016) (0)
Peter C. Doherty: A Legacy of Mentoring (2020) (0)
Aligned Silver Nanorod Array as SERS Substrates for Viral Sensing (2006) (0)
The Use of RNAi Technology in the Development of High Performance Bioproduction Cell Lines (2014) (0)
Risk Assessment and Anti-Viral Approaches for Novel H7N9 Influenza Virus (2013) (0)
Immunity to virus infection (excluding retroviruses) (PP-025) (2010) (0)
Viral Modulation of Host Translation and Implications for Vaccine Development (2018) (0)
MicroRNA-134 regulates poliovirus replication by IRES targeting (2017) (0)
Biology and transmission of avian influenza virus. (2008) (0)
Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein (2023) (0)
mir‐548n Expression in HEPG2 and HEP2 cells Is Affected By The Culture Medium Zinc Concentration (2015) (0)
Structural basis for ultrapotent neutralization of human metapneumovirus (2022) (0)
Generation of H7N9-specific human polyclonal antibodies from a transchromosomic goat (caprine) system (2019) (0)
NK cells modify anti-influenza CD8 T cell responses and memory formation (VIR2P.1014) (2014) (0)
A potently neutralizing site III-specific human antibody prevents human metapneumovirus replication in vivo (2019) (0)
Corrigendum to "Molecular epidemiology of swine influenza A viruses in the Southeastern United States, highlights regional differences in circulating strains'' [Vet. Microbiol. 211 (2017) 174-179]. (2017) (0)
Detection and Differentiation of Avian Mycoplasmas by Surface-Enhanced Raman 1 Spectroscopy Based on Silver Nanorod Array 2 3 (2011) (0)
Editorial: Understanding the Limitations of Current Influenza Vaccine Strategies and Future Development of More Efficacious Preventative and Therapeutic Interventions (2019) (0)
Clinical development of pandemic influenza vaccines. (2008) (0)
MicroRNAs affect GPCR and Ion channel genes needed for influenza replication (2021) (0)
Virus Production Protein Modulates M Oligomerization and Respiratory Syncytial Virus Matrix ( M ) The Thr 205 Phosphorylation Site within (2014) (0)
Zinc affects miR-548n, SMAD4, SMAD5 expression in HepG2 hepatocyte and HEp-2 lung cell lines (2015) (0)
Small Non-coding RNA Expression Following Respiratory Syncytial Virus or Measles Virus Infection of Neuronal Cells (2021) (0)
DETECTION OF VIRUSES AND METHODS OF USE THEREOF (2017) (0)
A Review on Health Effects of Ambient Air Pollution on Children (2013) (0)
Future Microbiology The host response and molecular pathogenesis associated with respiratory syncytial virus infection (2009) (0)
Genetic engineering of enhanced vaccine cell lines to eradicate poliovirus and other vaccine preventable diseases (2014) (0)
Countermeasures to Address the Ebloa Virus (EBOV) Threat (2014) (0)
Dual oxidase1 ameliorates survival, viral clearance and pulmonary pathology during influenza infection (2019) (0)
Subsisting H 1 N 1 influenza memory responses are insufficient to protect from pandemic H 1 N 1 influenza challenge in C 57 BL / 6 mice (2013) (0)
Vaccines for influenza virus. (2008) (0)
ECM remodelling by ADAMTS5 regulates influenza-specific immunity following acute infection (2016) (0)
Visible Light-Induced Photoeletrochemical and Antimicrobial Properties of Hierarchical CuBi2O4 by Facile Hydrothermal Synthesis. (2016) (0)

This paper list is powered by the following services:

Other Resources About Ralph A. Tripp

vet.uga.edu

What Schools Are Affiliated With Ralph A. Tripp?

Ralph A. Tripp is affiliated with the following schools: